Format

Send to

Choose Destination
Circulation. 2014 Sep 30;130(14):1192-203. doi: 10.1161/CIRCULATIONAHA.113.008428.

Challenges and priorities for research: a report from the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (NIH) Working Group on thrombosis in pediatric cardiology and congenital heart disease.

Author information

1
From the Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada (B.W.M., C.M., L.R.B.); Duke University Medical Center, Duke University, Durham, NC (J.S.L., T.L.O.); Children's Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI (J.S.T.); Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (T.M.G., R.I.); Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada (M.P.M.); Royal Children's Hospital, Murdoch Children's Research Institute, University of Melbourne, Melbourne, Australia (P.M.); Texas Children's Hospital, Baylor College of Medicine, Houston, TX (R.K.); Department of Medicine, Stanford University School of Medicine, Stanford, CA (K.W.M.); Boston Children's Hospital, Harvard Medical School, Boston, MA (A.D.M., C.S.A., J.W.N.); Children's National Medical Center, George Washington University, Washington, DC (N.V.); Coagulation Biology Laboratory, Oklahoma Medical Research Foundation, Oklahoma City, OK (C.T.E.); Children's Hospital of Colorado, University of Colorado, Aurora, CO (M.J.M-.J.); McMaster Children's Hospital, McMaster University, Hamilton, Ontario, Canada (A.K.C.); Bristol-Myers Squibb, Princeton, NJ (R.P.); Division of Cardiovascular and Renal Protocol, Food & Drug Administration, Silver Spring, MD (M.R.); Merck, Whitehouse Station, NJ (J.S.); and Division of Cardiovascular Sciences, NHLBI/NIH, Bethesda, MD (J.R.K.). brian.mccrindle@sickkids.ca.
2
From the Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada (B.W.M., C.M., L.R.B.); Duke University Medical Center, Duke University, Durham, NC (J.S.L., T.L.O.); Children's Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI (J.S.T.); Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (T.M.G., R.I.); Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada (M.P.M.); Royal Children's Hospital, Murdoch Children's Research Institute, University of Melbourne, Melbourne, Australia (P.M.); Texas Children's Hospital, Baylor College of Medicine, Houston, TX (R.K.); Department of Medicine, Stanford University School of Medicine, Stanford, CA (K.W.M.); Boston Children's Hospital, Harvard Medical School, Boston, MA (A.D.M., C.S.A., J.W.N.); Children's National Medical Center, George Washington University, Washington, DC (N.V.); Coagulation Biology Laboratory, Oklahoma Medical Research Foundation, Oklahoma City, OK (C.T.E.); Children's Hospital of Colorado, University of Colorado, Aurora, CO (M.J.M-.J.); McMaster Children's Hospital, McMaster University, Hamilton, Ontario, Canada (A.K.C.); Bristol-Myers Squibb, Princeton, NJ (R.P.); Division of Cardiovascular and Renal Protocol, Food & Drug Administration, Silver Spring, MD (M.R.); Merck, Whitehouse Station, NJ (J.S.); and Division of Cardiovascular Sciences, NHLBI/NIH, Bethesda, MD (J.R.K.).

KEYWORDS:

antithrombotic agents; cardiology; pediatrics; thrombosis

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center